沪深市场个股详情
300878 维康药业
- 18.70
- -0.36-1.89%
交易中 11/18 11:03 (北京)
27.08亿总市值-81304市盈率TTM
19.40最高价18.22最低价3.02万手成交量19.24今开19.06昨收5667.23万成交额5.43%换手率亏损市盈率(静)1.45亿总股本31.7552周最高2.01市净率10.40亿流通值13.3152周最低22.87涨停价5561.54万流通股59.90历史最高15.25跌停价6.19%振幅13.31历史最低0.25股息TTM18.75平均价1.67万手内盘1.34%股息率TTM100股每手1.16万手外盘
维康药业关键统计数据
全部
显示同比
| (Q9)2024/09/30 | (Q6)2024/06/30 | (Q3)2024/03/31 | (FY)2023/12/31 | (Q9)2023/09/30 | (Q6)2023/06/30 | (Q3)2023/03/31 | (FY)2022/12/31 | (Q9)2022/09/30 | (Q6)2022/06/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | -14.16%3.71亿 | -6.15%2.97亿 | 2.15%2亿 | -2.41%5.2亿 | -8.93%4.32亿 | 7.04%3.16亿 | 6.50%1.96亿 | -15.88%5.32亿 | -5.40%4.74亿 | -10.91%2.96亿 |
| 营业收入 | -14.16%3.71亿 | -6.15%2.97亿 | 2.15%2亿 | -2.41%5.2亿 | -8.93%4.32亿 | 7.04%3.16亿 | 6.50%1.96亿 | -15.88%5.32亿 | -5.40%4.74亿 | -10.91%2.96亿 |
| 其他业务收入 | ---- | 9.42%246.07万 | ---- | --506.56万 | ---- | 12.56%224.88万 | ---- | ---- | ---- | 412.42%199.78万 |
| 营业总成本 | 15.38%4.15亿 | 8.07%2.85亿 | 5.33%1.74亿 | 13.37%5.6亿 | -5.05%3.59亿 | 7.03%2.64亿 | 1.34%1.65亿 | -8.16%4.94亿 | -3.94%3.79亿 | -5.44%2.47亿 |
| 营业成本 | 7.90%1.95亿 | 2.29%1.44亿 | -3.83%1.02亿 | 17.66%2.58亿 | 4.36%1.81亿 | 21.95%1.41亿 | 20.12%1.06亿 | 7.19%2.19亿 | 29.03%1.73亿 | 21.38%1.15亿 |
| 营业税金及附加 | 599.98%905.22万 | 719.62%557.99万 | 2,717.77%472.18万 | 47.68%281.36万 | 22.67%129.32万 | -30.08%68.08万 | -79.22%16.76万 | -60.27%190.52万 | -67.27%105.42万 | -51.49%97.37万 |
| 销售费用 | 32.10%1.63亿 | 26.26%1.06亿 | 30.78%5,233.69万 | 7.85%2.08亿 | -13.44%1.24亿 | -10.95%8,367.99万 | -29.87%4,001.78万 | -28.50%1.93亿 | -37.08%1.43亿 | -35.33%9,396.75万 |
| 管理费用 | 15.76%3,316.95万 | 16.08%2,178.37万 | 25.20%1,077.38万 | 9.60%4,094.16万 | 3.38%2,865.33万 | 6.10%1,876.68万 | -1.88%860.54万 | 50.93%3,735.53万 | 55.69%2,771.74万 | 51.42%1,768.78万 |
| 财务费用 | -62.31%196.94万 | -53.62%165.49万 | -24.60%95.7万 | 127.40%756.21万 | -8.11%522.47万 | 423.19%356.84万 | 2,018.35%126.93万 | 209.69%332.55万 | 253.39%568.58万 | 126.32%68.21万 |
| -利息费用 | -31.32%420.02万 | -21.14%318.28万 | -6.59%124.22万 | 74.69%944.97万 | -14.31%611.56万 | 293.39%403.59万 | 199.35%132.98万 | 150.52%540.95万 | 9,754.63%713.69万 | 1,316.61%102.59万 |
| -利息收入 | -65.34%-231.5万 | -65.70%-157.69万 | -43.98%-61.65万 | 11.97%-197.89万 | 11.73%-140.01万 | 19.68%-95.17万 | 19.84%-42.82万 | 57.46%-224.79万 | 62.71%-158.61万 | 59.30%-118.49万 |
| 研发费用 | -38.69%1,218.07万 | -60.08%658.03万 | -66.40%297.12万 | 8.84%4,279.82万 | -29.22%1,986.62万 | -7.66%1,648.41万 | 13.23%884.17万 | 6.23%3,932.04万 | 80.05%2,806.73万 | 92.54%1,785.11万 |
| 信用减值损失 | -171.10%-658.84万 | -135.40%-394.53万 | -4.68%-497.8万 | 256.85%1,146.11万 | 1,308.75%926.7万 | 605.90%1,114.37万 | -298.51%-475.56万 | 13.10%-730.71万 | 107.75%65.78万 | 118.47%157.86万 |
| 资产减值损失 | 1.70%-12.37万 | -33.17%-9.22万 | 0.00%-3.46万 | -232.80%-73.7万 | 33.45%-12.59万 | 45.10%-6.92万 | 45.10%-3.46万 | -152.29%-22.14万 | ---18.91万 | ---12.61万 |
| 非经营性净收益 | 325.25%9,192.85万 | -91.93%171.87万 | -76.25%56.95万 | 49.19%3,943.06万 | 26.54%2,161.73万 | 25.79%2,130.25万 | -55.11%239.74万 | 547.51%2,643.05万 | 493.91%1,708.35万 | 540.19%1,693.49万 |
| 公允价值变动净收益 | ---- | ---- | --219.28万 | --456.46万 | ---- | ---- | ---- | ---- | ---- | ---- |
| 投资净收益 | 1,178.66%9,210.79万 | -70.23%214.48万 | -79.11%124.51万 | -6.22%1,386.79万 | 245.71%720.35万 | 245.71%720.35万 | 186.02%595.97万 | 5,494.56%1,478.81万 | --208.37万 | --208.37万 |
| -其中:对联营合营企业的投资收益 | ---- | ---- | ---- | ---21.76万 | ---- | ---- | ---- | ---- | ---- | ---- |
| 资产处置收益 | -2,120.19%-25.11万 | -2,282.77%-27.13万 | ---3.05万 | 99.08%-5,821.95 | 122.88%1.24万 | 120.83%1.24万 | ---- | -1,038.94%-63.45万 | -180.86%-5.43万 | -3,067.29%-5.97万 |
| 其他收益 | 28.96%678.39万 | 28.90%388.27万 | 77.11%217.48万 | -48.10%1,027.98万 | -63.93%526.03万 | -77.62%301.21万 | 32.60%122.79万 | 61.72%1,980.54万 | 29.17%1,458.55万 | 20.22%1,345.84万 |
| 营业利润 | -48.98%4,806.14万 | -81.64%1,356.79万 | -19.39%2,663.41万 | -101.56%-101.35万 | -16.56%9,419.65万 | 11.87%7,389.31万 | 26.06%3,303.95万 | -34.59%6,485.09万 | 2.41%1.13亿 | -10.47%6,604.97万 |
| 加:营业外收入 | 5,654.69%308.23万 | 5,502.90%279.94万 | -68.17%3.58万 | 25.83%51.88万 | -88.17%5.36万 | -85.40%5万 | -59.10%11.25万 | -59.96%41.23万 | -53.84%45.26万 | -32.38%34.23万 |
| 减:营业外支出 | 41.73%731.56万 | -53.48%26.95万 | -38.69%31.88万 | 150.33%529.12万 | 1,022.19%516.16万 | 95.41%57.93万 | 184.92%51.99万 | 1,371.00%211.37万 | 580.66%46万 | 916.37%29.64万 |
| 利润总额 | -50.80%4,382.82万 | -78.06%1,609.78万 | -19.25%2,635.11万 | -109.16%-578.59万 | -21.08%8,908.85万 | 11.00%7,336.38万 | 24.07%3,263.2万 | -36.87%6,314.95万 | 1.56%1.13亿 | -10.99%6,609.56万 |
| 减:所得税费用 | -113.05%-237.69万 | -98.50%11.75万 | -57.48%196.18万 | -97.08%39.86万 | -0.15%1,821.51万 | -8.59%783.82万 | 45.41%461.42万 | 292.64%1,366.73万 | -0.78%1,824.33万 | -19.87%857.44万 |
| 净利润 | -34.81%4,620.51万 | -75.61%1,598.03万 | -12.95%2,438.93万 | SL-618.45万 | -25.12%7,087.33万 | 13.92%6,552.55万 | 21.14%2,801.78万 | -48.75%4,948.21万 | 2.02%9,464.34万 | -9.49%5,752.12万 |
| 持续经营净利润 | -34.81%4,620.51万 | -75.61%1,598.03万 | -12.95%2,438.93万 | -112.50%-618.45万 | -25.12%7,087.33万 | 13.92%6,552.55万 | 21.14%2,801.78万 | -48.75%4,948.21万 | 2.02%9,464.34万 | -9.49%5,752.12万 |
| 减：少数股东损益 | 38.41%210.76万 | 97.62%178.82万 | -88.95%5.43万 | 175.94%185.41万 | 113.73%152.27万 | 68.98%90.49万 | 135.91%49.18万 | 1,197.89%67.19万 | 1,387.39%71.24万 | 344.89%53.55万 |
| 归属于母公司所有者的净利润 | -36.41%4,409.75万 | -78.04%1,419.21万 | -11.59%2,433.5万 | -116.47%-803.86万 | -26.17%6,935.06万 | 13.40%6,462.07万 | 20.10%2,752.6万 | -49.42%4,881.02万 | 1.31%9,393.09万 | -10.64%5,698.57万 |
| 每股收益 | ||||||||||
| 基本每股收益 | -35.42%0.31 | -77.78%0.1 | -10.53%0.17 | -117.65%-0.06 | -26.01%0.48 | 14.33%0.45 | -33.31%0.19 | -49.25%0.34 | -43.72%0.6487 | -50.37%0.3936 |
| 稀释每股收益 | -35.42%0.31 | -77.78%0.1 | -10.53%0.17 | -117.65%-0.06 | -26.01%0.48 | 14.33%0.45 | -33.31%0.19 | -49.25%0.34 | -43.72%0.6487 | -50.37%0.3936 |
| 其他综合收益 | ||||||||||
| 综合收益总额 | -34.81%4,620.51万 | -75.61%1,598.03万 | -12.95%2,438.93万 | -112.50%-618.45万 | -25.12%7,087.33万 | 13.92%6,552.55万 | 21.14%2,801.78万 | -48.75%4,948.21万 | 2.02%9,464.34万 | -9.49%5,752.12万 |
| 归属于母公司所有者的综合收益总额 | -36.41%4,409.75万 | -78.04%1,419.21万 | -11.59%2,433.5万 | -116.47%-803.86万 | -26.17%6,935.06万 | 13.40%6,462.07万 | 20.10%2,752.6万 | -49.42%4,881.02万 | 1.31%9,393.09万 | -10.64%5,698.57万 |
| 归属于少数股东的综合收益总额 | 38.41%210.76万 | 97.62%178.82万 | -88.95%5.43万 | 175.94%185.41万 | 113.73%152.27万 | 68.98%90.49万 | 135.91%49.18万 | 1,197.89%67.19万 | 1,387.39%71.24万 | 344.89%53.55万 |
| 货币单位 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 |
| 会计准则 | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) |
| 审计意见 | -- | -- | -- | 带解释性说明的保留意见 | -- | -- | -- | 无保留意见 | -- | -- |
| 会计师事务所 | -- | -- | -- | 天健会计师事务所(特殊普通合伙) | -- | -- | -- | 天健会计师事务所(特殊普通合伙) | -- | -- |
FY：Financial Year 年度报告，相当于上市公司向SEC披露的10-K文件。
Q：Quarter 季度报告，相当于上市公司向SEC披露的10-Q文件，其中Q1、Q2、Q3、Q4为单季报，跨度为3个月；Q6、Q9为累计季报，Q6为6个月，Q9为9个月。
分析
目标价预测
暂无数据
热议
沪深
综合热度
股票代码
最新价
涨跌幅
暂无数据